dr. hamilton on the fda approval of tucatinib in her2 breast cancer
Published 4 years ago • 935 plays • Length 1:10Download video MP4
Download video MP3
Similar videos
-
2:15
dr. hamilton on the promise of tucatinib in her2 breast cancer brain metastases
-
0:43
dr. hamilton on fda approval of adjuvant pertuzumab regimen in her2 early breast cancer
-
0:51
dr. hamilton discusses tucatinib in her2 breast cancer
-
1:13
dr. hamilton on the efficacy of trastuzumab deruxtecan in her2-low breast cancer
-
0:56
dr. hamilton on recent advances in her2 breast cancer
-
17:53
dr. murthy on the clinical implications of tucatinib approval in her2 breast cancer
-
1:05
dr. hamilton on the evolution of treatment in her2 breast cancer
-
1:16
dr. hamilton on the complex treatment algorithm for her2 breast cancer
-
1:10
dr. valdes-albini on the fda approval of adjuvant pertuzumab in her2 breast cancer
-
1:14
dr. hamilton on how neratinib targets her2 breast cancer
-
1:07
dr. hamilton on the results of the nextmonarch trial in patients with hr /her2- breast cancer
-
3:08
the benefits of tucatinib in her2 breast cancer
-
1:53
dr. hamilton on adjuvant therapy for her2 breast cancer
-
1:07
dr. hamilton on the destiny-breast01 trial in her2 breast cancer
-
1:42
dr. hamilton on the her2climb trial in metastatic her2 breast cancer
-
8:33
pending fda approval of neratinib in her2 breast cancer
-
1:18
dr. hamilton discusses the katherine trial in her2 breast cancer
-
0:51
dr. hamilton on extended adjuvant therapy for her2 breast cancer
-
1:13
dr. hamilton on overcoming resistance to her2-targeted therapy in breast cancer